Workshops Based on the A-MAb Case Study
Members of the CMC Biotech Working Group will participate in various public workshops hosted by ISPE and CASSS, who have been designated as the primary facilitators of education related to the A-MAb Case Study. Sessions will be held during three 2010 CASSS events, including the CMC Strategy Forum Europe [http://www.casss.org/cde.cfm?event=265809] in Vienna, in April, and the CMC Strategy Forum [ http://www.casss.org/cde.cfm?event=285435] in Bethesda, MD, in July. Workshops also will be incorporated into already scheduled ISPE 2010 meetings, in Milan [http://www.ispe.org/milancongress] in March, Tokyo [http://www.ispe.org/cs/root/education_and_training/events/japan_affiliate_annual_meeting_including_pqli] in April, Washington, DC [http://www.ispe.org/2010washingtonconference], in June, and Brussels [http://www.ispe.org/cs/2010_brussels_conference/conference_programme] in September.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
2 Commerce Drive
Cranbury, NJ 08512